Trial site
St Bartholomew's Hospital, Barts Health NHS Trust
London, EC1A 7BE, United KingdomNot linked to an institution yet
- 14running trials
- 5closed trials
The trials here
What the 19 trials at this site are about, from their registry records.
- Phase
- Phase 38 trials
- Phase 25 trials
- Status
- Active, not recruiting7 trials
- Recruiting6 trials
- Completed5 trials
- Not yet recruiting1 trial
- Lead sponsor
- BioNTech SE3 trials
- Pfizer2 trials
- Queen Mary University of London2 trials
- University College, London2 trials
- University of Birmingham2 trials
- and 8 more
Running trials
Recruiting
Study of Zoldonrasib + Chemo of Investigator's Choice vs Placebo + Chemo of Investigator's Choice as First-line Treatment in Metastatic KRAS G12D-mutated Pancreatic Adenocarcinoma ( RASolute 305 )
NCT07621718· Phase 3· Revolution Medicines, Inc.· Source
Contact: Revolution Medicines Study Director
Recruiting
AIC Genotyping Study
NCT07574697· Barts & The London NHS Trust· Source
Contact: Nikhil Ahluwalia
Recruiting
A Prospective, Multicenter, Randomized Controlled Trial to Investigate the Value of Coronary CT Angiography in the Understanding and Management of Coronary Calcium (The Optimal Trial)
NCT07286578· Fundación EPIC· Source
Contact: CAROLINA FOCELLA
Recruiting
ROSETTA Breast-01: The Effects and Safety of Pumitamig in Patients With Triple-Negative Breast Cancer
NCT07173751· Phase 3· BioNTech SE· Source
Not yet recruiting
Transcutaneous Vagus Nerve Stimulation for Ventricular Arrhythmias
NCT07026695· University College, London· Source
Contact: Nikhil Ahluwalia, MBBS, PhD
Active, not recruiting
Safety and Preliminary Effectiveness of BNT327, an Investigational Therapy for Breast Cancer, When Given in Combination With Chemotherapy
NCT06449222· Phase 2· BioNTech SE· Source
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
NCT06012435· Phase 3· Seagen, a wholly owned subsidiary of Pfizer· Source
Recruiting
Physiological Versus Right Ventricular Outcome Trial Evaluated for Bradycardia Treatment Upgrades
NCT06052475· Imperial College London· Source
Contact: Amal Muthumala
Active, not recruiting
ARISTOCRAT: Blinded Trial of Temozolomide +/- Cannabinoids
NCT05629702· Phase 2· University of Birmingham· Source
Active, not recruiting
Zimberelimab and Domvanalimab in Combination With Chemotherapy Versus Pembrolizumab With Chemotherapy in Patients With Untreated Metastatic Non-Small Cell Lung Cancer
NCT05502237· Phase 3· Gilead Sciences· Source
Active, not recruiting
A Phase II Clinical Trial Comparing the Efficacy of RO7198457 Versus Watchful Waiting in Patients With ctDNA-positive, Resected Stage II (High Risk) and Stage III Colorectal Cancer
NCT04486378· Phase 2· BioNTech SE· Source
Active, not recruiting
A Clinical Trial of Three Study Medicines (Encorafenib, Binimetinib, and Pembrolizumab) in Patients With Advanced or Metastatic Melanoma
NCT04657991· Phase 3· Pfizer· Source
Active, not recruiting
A Study to Assess the Efficacy, Safety, Pharmacodynamics, and Pharmacokinetics of Tazemetostat in Combination With Lenalidomide Plus Rituximab Versus Placebo in Combination With Lenalidomide Plus Rituximab in Adult Patients at Least 18 Years of Age With Relapsed/Refractory Follicular Lymphoma.
NCT04224493· Phase 3· Epizyme, Inc.· Source
Recruiting
Periodontal Assessment of a Bariatric Care Population
NCT04851470· Queen Mary University of London· Source
Contact: Anjali Zalin, Dr
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
Report an error